<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> and <z:chebi fb="3" ids="44915">propofol</z:chebi> are neuroprotective possibly by attenuating central or peripheral <z:chebi fb="2" ids="33567">catecholamines</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the effect of these <z:chebi fb="37" ids="38867">anesthetics</z:chebi> on circulating <z:chebi fb="2" ids="33567">catecholamines</z:chebi> and brain <z:chebi fb="65" ids="25512">neurotransmitters</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rats </plain></SENT>
<SENT sid="2" pm="."><plain>Forty male Sprague-Dawley rats were randomly assigned to one of the following treatment groups: fentanyl and N(2)O/<z:chebi fb="0" ids="15379">O(2)</z:chebi> (control), 2.0% <z:chebi fb="0" ids="9130">sevoflurane</z:chebi>, 0.8-1.2 mg x kg(-1) x min(-1) of <z:chebi fb="3" ids="44915">propofol</z:chebi>, and sham-operated rats with fentanyl and N(2)O/<z:chebi fb="0" ids="15379">O(2)</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> (30 min) was produced by unilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> plus hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> to a mean arterial blood pressure of 32 +/- 2 mm Hg </plain></SENT>
<SENT sid="4" pm="."><plain>Pericranial temperature, arterial blood gases, and pH value were maintained constant </plain></SENT>
<SENT sid="5" pm="."><plain>Cerebral <z:chebi fb="2" ids="33567">catecholamine</z:chebi> and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentrations, sampled by microdialysis, and plasma <z:chebi fb="2" ids="33567">catecholamine</z:chebi> concentrations were analyzed using high-pressure liquid chromatography </plain></SENT>
<SENT sid="6" pm="."><plain>During <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, circulating <z:chebi fb="2" ids="33567">catecholamines</z:chebi> were almost completely suppressed by <z:chebi fb="3" ids="44915">propofol</z:chebi> but only modestly decreased with <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> and <z:chebi fb="3" ids="44915">propofol</z:chebi> suppressed brain <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> concentration increases by 75% and 58%, respectively, compared with controls </plain></SENT>
<SENT sid="8" pm="."><plain>Intra-<z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">ischemia cerebral</z:e> <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentration was decreased by 60% with both <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> and <z:chebi fb="3" ids="44915">propofol</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>These results question a role of circulating <z:chebi fb="2" ids="33567">catecholamines</z:chebi> as a common mechanism for cerebral protection during <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> and <z:chebi fb="3" ids="44915">propofol</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>A role of brain tissue <z:chebi fb="2" ids="33567">catecholamines</z:chebi> in mediating ischemic injury is consistent with our results </plain></SENT>
<SENT sid="11" pm="."><plain>IMPLICATIONS: During incomplete <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, the neuroprotective <z:chebi fb="37" ids="38867">anesthetics</z:chebi> <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> and <z:chebi fb="3" ids="44915">propofol</z:chebi> suppressed cerebral increases in <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> and <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentrations </plain></SENT>
<SENT sid="12" pm="."><plain>In contrast, <z:chebi fb="3" ids="44915">propofol</z:chebi>, but not <z:chebi fb="0" ids="9130">sevoflurane</z:chebi>, suppressed the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increase in circulating <z:chebi fb="2" ids="33567">catecholamines</z:chebi> to baseline levels </plain></SENT>
<SENT sid="13" pm="."><plain>The results question a role for plasma <z:chebi fb="2" ids="33567">catecholamines</z:chebi> in cerebral ischemic injury </plain></SENT>
</text></document>